Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.

Park JH, Jung KH, Kim SJ, Yoon YC, Yan HH, Fang Z, Lee JE, Lim JH, Mah S, Hong S, Kim YS, Hong SS.

Cancer Lett. 2019 Mar 1;444:94-104. doi: 10.1016/j.canlet.2018.12.006. Epub 2018 Dec 21.

PMID:
30583075
2.

Discovery of fluorescent 3-heteroarylcoumarin derivatives as novel inhibitors of anaplastic lymphoma kinase.

Mah S, Jang J, Song D, Shin Y, Latif M, Jung Y, Hong S.

Org Biomol Chem. 2018 Dec 19;17(1):186-194. doi: 10.1039/c8ob02874e.

PMID:
30534706
3.

HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis.

Park HH, Park SY, Mah S, Park JH, Hong SS, Hong S, Kim YS.

Exp Mol Med. 2018 Sep 20;50(9):125. doi: 10.1038/s12276-018-0152-8.

4.

Correction to Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design.

Mah S, Park JH, Jung HY, Ahn K, Choi S, Tae HS, Jung KH, Rho JK, Lee JC, Passerini CG, Fontana D, Hong SS, Hong S.

J Med Chem. 2018 Mar 8;61(5):2131. doi: 10.1021/acs.jmedchem.8b00212. Epub 2018 Feb 22. No abstract available.

PMID:
29470064
5.

Systematic Computational Design and Identification of Low Picomolar Inhibitors of Aurora Kinase A.

Park H, Jung HY, Mah S, Hong S.

J Chem Inf Model. 2018 Mar 26;58(3):700-709. doi: 10.1021/acs.jcim.7b00671. Epub 2018 Feb 16.

PMID:
29401391
6.

Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design.

Mah S, Park JH, Jung HY, Ahn K, Choi S, Tae HS, Jung KH, Rho JK, Lee JC, Hong SS, Hong S.

J Med Chem. 2017 Nov 22;60(22):9205-9221. doi: 10.1021/acs.jmedchem.7b01039. Epub 2017 Nov 9. Erratum in: J Med Chem. 2018 Mar 8;61(5):2131.

PMID:
29091425
7.

Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA.

Oh TI, Lee YM, Nam TJ, Ko YS, Mah S, Kim J, Kim Y, Reddy RH, Kim YJ, Hong S, Lim JH.

Int J Mol Sci. 2017 Sep 29;18(10). pii: E2074. doi: 10.3390/ijms18102074.

8.

Discovery of EGF Receptor Inhibitors That Are Selective for the d746-750/T790M/C797S Mutant through Structure-Based de Novo Design.

Park H, Jung HY, Mah S, Hong S.

Angew Chem Int Ed Engl. 2017 Jun 19;56(26):7634-7638. doi: 10.1002/anie.201703389. Epub 2017 May 22.

PMID:
28493467
9.

Discovery of Low Micromolar Dual Inhibitors for Wild Type and L1196M Mutant of Anaplastic Lymphoma Kinase through Structure-Based Virtual Screening.

Shin S, Mah S, Hong S, Park H.

J Chem Inf Model. 2016 Apr 25;56(4):802-10. doi: 10.1021/acs.jcim.6b00026. Epub 2016 Apr 4.

PMID:
27014917
10.

Catalyst Controlled Divergent C4/C8 Site-Selective C-H Arylation of Isoquinolones.

Lee S, Mah S, Hong S.

Org Lett. 2015 Aug 7;17(15):3864-7. doi: 10.1021/acs.orglett.5b01840. Epub 2015 Jul 28.

PMID:
26218668

Supplemental Content

Loading ...
Support Center